SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Munch-a-Biotech Today
An SI Board Since December 1998
Posts SubjectMarks Bans
3158 136 0
Emcee:  Biomaven Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2033>> What's wrong with going via mouse? << Mice "look like&qscaram(o)uche-12/15/2005
2032Animals, mammals, "mature" an immune response after exposure to antigescaram(o)uche-12/15/2005
2031kenhott: Don't have your answer 'cause your question went right over my fred hayes-12/15/2005
2030PDLI had a pretty good bounce this morning, FWIW (has given a chunk back). Ituck-12/15/2005
2029When would someone want to go with a mouse-derived humab? TIA.kenhott-12/15/2005
2028<i>only one....</i> Got my MEDX. :-) I see they've reacted; I&nigel bates-12/15/2005
2027The value of all antibody therapeutics companies just went up, imo. If you'scaram(o)uche-12/15/2005
2026No price reaction in CAT or Morphosys this morning. Should there be ....? <nigel bates-12/15/2005
2025not enough shares short, but better than a kick in the pants (yahoo says 16% of scaram(o)uche-12/14/2005
2024If it's all the same to you, Dew, I'd like to vote here - Negative.tom pope-12/14/2005
2023Survey: How does AMGN’s buyout of ABGX for $2.2B affect the likelihood that IMDewDiligence_on_SI-12/14/2005
2022abgx munched by amgnscaram(o)uche-12/14/2005
2021J&J Reaches Out To Wall Street In Guidant Duel By DENNIS K. BERMAN Staff RDoc Bones-12/12/2005
2020Guess we'll know soon if there are any takers... <pre> LONDON, ENGLAnigel bates-12/8/2005
2019At current prices, Amgen will be spending about 18 months profit to buyback $5B John Metcalf-12/7/2005
2018Amgen buying back $5 billion in stock. (eom)scaram(o)uche-12/7/2005
2017Boston Scientific: From Start-Up to Upstart History Shows Medical-Device Firm Doc Bones-12/7/2005
2016Johnson & Johnson May Have Blown Guidant Bid With Short-Term Greed [WSJ] LODoc Bones-12/7/2005
2015Cephalon, Inc. Announces Agreement to Acquire Zeneus Holdings Limited Tuesday DIcebrg-12/6/2005
2014I have to wonder if we'll see QLTI here on Thursday???? <i>QLT to hosIan@SI-12/5/2005
2013Analysts React to Guidant Bid [WSJ] December 5, 2005 3:01 p.m. Boston ScientifDoc Bones-12/5/2005
2012Troubled Maker of Heart Devices Gains Another Suitor [NYT] By VIKAS BAJAJ PubliDoc Bones-12/5/2005
2011Bait And Switch: American Pharmaceutical Partners’ Proposed Acquisition of AmeriIcebrg-12/2/2005
2010Abraxis Deal Is Most Abrasive Biotech Billionaire's High Valuation UnsettleDoc Bones-12/2/2005
2009<b>Crucell and Berna Biotech: Together Creating the Leading Independent VaDewDiligence_on_SI-12/1/2005
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News